Tuesday, September 16, 2014


IBRI introduce new course in Food Regulatory Affairs 6[Months].Deatils are as below......

The specific course has been framed with a perspective to endow knowledge of Food Regulatory Affairs for individuals employed in the food sector or those who wish to develop their career in food industry. The course incorporates Food items regulations in different regions of the world along with in India, approvals, risk analysis, HACCP etc.
Course Objectives
·         Gain the essential knowledge and skills required to help companies navigate an increasingly complex regulatory environment in relation to food items etc.
·         Analyze how emerging developments and trends are reshaping food products regulations
Course- Structure
 Course-Paper-I: Introduction to the European Union and Food Regulatory Affairs
Course-Paper-II International Food Regulatory Affairs and Current issues
Course-Paper-III Food Regulatory Affairs in India (FSSAI, Approvals etc.)
Course-Paper-IV Risk Analysis, HACCP, and Health
Careers Opportunities
This qualification will lead to employment opportunities in government (EU and international) and non-government organizations, and in the European and international agri-food industry. The knowledge and understanding of legislative, policy and scientific aspects of food regulatory affairs will help to develop the intellectual and higher level skills of critical analysis, judgement and evaluation in addition to a range of transferable and communication skills
Course Fees: - Rs 10500/-(Student Participating from India) / 350 USD (Student Participating from Overseas)

Study Material for the course: - Complete study material will be provided by the institute in printed book form, PPT and Video Lectures.

Examination and Evaluation Process: - One time examination and mode of examination are
· Assignment Based Examination
· Examination Center based Examination
· Evaluation by experts from industry and academic team of institute.

How to join this course?
· Download Registration Form from website or from attachment in mail.
· Fill it completely and attach 10th, graduation and one photograph for ID card.
· Send it by Registered Post or Courier to institute address given below-
C 50, First Floor, Sector 2, Noida 201301 (UP) India
Phone: 01204122315, Mob: 9999509892

Posted by:Indian Biological Sciences and Research Institute, NOIDA

Friday, September 12, 2014

SC seeks records of cervical cancer vaccine's clinical trials

NEW DELHI: Taking serious note of alleged death of seven tribal girls in Andhra Pradesh, Telangana and Gujarat during clinical trials of a cervical cancer vaccine, the Supreme Court on Tuesday asked the central drug control authority and Indian Council for Medical Research to tell how permission for human trial of the drug was given. 

A bench of Justices Dipak Misra and V Gopala Gowda summoned the files relating to grant of permission for conducting clinical trial of a cervical cancer prevention vaccine in 2012. 

The bench also asked the Centre to produce all files relating to grant of licence for trial of the vaccine to prevent human papyloma virus (HPV) which causes cervical cancer. The drug is produced by pharma majors Glaxo Smithkline and Merck. The court asked relevant files to be produced on October 28. 

Dealing with a set of two PILs on clinical trials, the court wondered how a drug was licensed to be sold in India by the Drug Controller General of India (DCGI) and ICMR, even though it had allegedly caused death and severe ailments to tribal girls. 

It said, "We are concerned whether before drug was accepted to be used in India and whether DCGI and ICMR had followed procedure for its introduction." Counsel for petitioner, senior advocate Colin Gonsalves and Anand Grover, referred to an August 30, 2013 report by the parliamentary standing committee that painted a dismal picture of drug trials in India. 

The bench asked the Centre to detail an action taken report on the recommendations by the parliamentary standing committee. 

The bench also sought responses from Andhra Pradesh, Gujarat and Telangana, which had granted permission for the trial. 

It asked the states to explain why tribal areas were selected for trial and whether proper monitoring of the trial was done by following the laid down procedure. It also asked them to explain whether the procedure was followed in taking the consent of the girls, some of whom were minors, and what medical aid was given by the state to the affected girls.

Posted by:-Indian Biological Sciences and Research Institue, NOIDA